Search for the latest updates on diabetes
News
FDA accepts Boston's IND to begin clinical trial of BTI-320 to treat type 2 diabetes and weight loss Pharmaceutical Business Review - 27 minutes
The US Food and Drug Administration (FDA) has accepted Boston Therapeutics' investigational new drug (IND) application to start a clinical ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment